Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | EP300 | Q09472 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | PGR | P06401 | 3/20 | 0.32 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 3/20 | 0.31 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | STAT1 | P42224 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CDK2 | P24941 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27177909 | 0.81 | KDM4E (0.35) | KDM4EALDH1A1MAPTSMN1; SMN2HPGD | |
| SCHEMBL29351705 | 0.77 | ALDH1A1 (0.69) | KDM4EALDH1A1MAPTSMN1; SMN2HPGD | |
| SCHEMBL37694 | 0.77 | ALDH1A1 (0.69) | KDM4EALDH1A1MAPTSMN1; SMN2HPGD | |
| SCHEMBL1518273 | 0.77 | EP300 (0.62) | KDM4EALDH1A1MAPTSMN1; SMN2HPGD | |
| SCHEMBL2578895 | 0.77 | MAOB (0.49) | KDM4EALDH1A1MAPTSMN1; SMN2HPGD | |
| SCHEMBL7151872 | 0.76 | KDM4E (0.33) | KDM4EALDH1A1MAPTSMN1; SMN2HPGD | |
| Ethylene SCHEMBL28055534 | 0.76 | ALDH1A1 (0.67) | KDM4EALDH1A1MAPTSMN1; SMN2HPGD | |
| SCHEMBL18335524 | 0.76 | KDM4E (0.37) | KDM4EALDH1A1MAPTSMN1; SMN2HPGD | |
| Acetic Acid SCHEMBL723858 | 0.68 | ALDH1A1 (0.57) | KDM4EALDH1A1MAPTSMN1; SMN2HPGD | |
| SCHEMBL28649238 | 0.67 | ALDH1A1 (0.71) | KDM4EALDH1A1MAPTSMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240102991-A1 | Synthetic Fluorescent Protein Biosensors and Use Thereof in Drug Screening Methods | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-03-28 | — | — | US | disclosed |
| US-20210181181-A1 | Synthetic Fluorescent Protein Biosensors and Use Thereof in Drug Screening Methods | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE | 2021-06-17 | — | — | US | disclosed |
| US-20200055896-A1 | SUBSTRATES RECOGNIZED BY FIBROBLAST ACTIVATION PROTEIN (FAP) AND METHODS OF USING THE SAME | GENENTECH, INC. | 2020-02-20 | — | — | US | disclosed |
| EP-3606939-A1 | SUBSTRATES RECOGNIZED BY FIBROBLAST ACTIVATION PROTEIN (FAP) AND METHODS OF USING THE SAME | H. Hoffnabb-La Roche Ag (CH) | 2020-02-12 | — | — | EP | disclosed |
| EP-3541960-A2 | METHODS AND DEVICES FOR DETECTING HEPATITIS C VIRUS | Quest Diagnostics Investments LLC (US) | 2019-09-25 | — | — | EP | disclosed |
| WO-2019118837-A1 | SYNTHETIC FLUORESCENT PROTEIN BIOSENSORS AND USE THEREOF IN DRUG SCREENING METHODS | THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE (US) | 2019-06-20 | — | — | WO | disclosed |
| WO-2018187418-A1 | SUBSTRATES RECOGNIZED BY FIBROBLAST ACTIVATION PROTEIN (FAP) AND METHODS OF USING THE SAME | GENENTECH, INC. (US) | 2018-10-11 | — | — | WO | disclosed |
| WO-2017182834-A1 | NEW METHOD FOR TREATING RESISTANT GLIOBLASTOMA | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2017-10-26 | — | — | WO | disclosed |
| US-20160356776-A1 | Methods and Compositions for Detecting Botulinum Neurotoxin | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-12-08 | — | — | US | disclosed |
| US-20150253326-A1 | Methods and Compositions for Detecting Botulinum Neurotoxin | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-09-10 | — | — | US | disclosed |
| US-8999649-B2 | Method and compositions for detecting botulinum neurotoxin | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2015-04-07 | — | — | US | disclosed |
| EP-2718467-A2 | METHODS OF IDENTIFYING AN ORGANISM | Opgen, Inc. (US) | 2014-04-16 | — | — | EP | disclosed |
| WO-2013016420-A1 | METHODS OF IDENTIFYING AN ORGANISM | OPGEN, INC. (US) | 2013-01-31 | — | — | WO | disclosed |
| EP-2536852-A2 | METHODS FOR DETECTING FETAL NUCLEIC ACIDS AND DIAGNOSING FETAL ABNORMALITIES | Sequenom, Inc. (US) | 2012-12-26 | — | — | EP | disclosed |
| WO-2012173866-A2 | METHODS OF IDENTIFYING AN ORGANISM | OPGEN, INC. (US) | 2012-12-20 | — | — | WO | disclosed |
| US-20120220490-A1 | METHOD AND COMPOSITIONS FOR DETECTING BOTULINUM NEUROTOXIN | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2012-08-30 | — | — | US | disclosed |
| WO-2011102998-A2 | METHODS FOR DETECTING FETAL NUCLEIC ACIDS AND DIAGNOSING FETAL ABNORMALITIES | HELICOS BIOSCIENCES CORPORATION (US) | 2011-08-25 | — | — | WO | disclosed |
| WO-2009085733-A1 | MULTIPLEX DETECTION ASSAY FOR INFLUENZA AND RSV VIRUSES | QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) | 2009-07-09 | — | — | WO | disclosed |
| WO-2007133189-A2 | METHODS AND AGENTS FOR DETECTING PARECHOVIRUS | THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES,CENTERS FOR DISEASE CONTROL AND PREVENTION (US) | 2007-11-22 | — | — | WO | disclosed |